Wellness & Lifestyle

Awesome-AI-Agents-for-Healthcare is a comprehensive, open-source repository that curates the latest advancements in Agentic AI and AI agents specifically tailored for the healthcare domain. This resource provides a meticulously organized collection of research papers, innovative projects, and valuable tools. It covers a wide array of applications, including medical image analysis, electronic health record (EHR) manipulation, counseling, drug discovery, patient dialogue systems, and healthcare administration. The repository also features a conceptual framework illustrating the pipeline from data perception to a hierarchical application ecosystem, alongside a quantitative analysis of academic literature highlighting key trends in data modalities, technologies, and application domains. It's an invaluable resource for researchers, developers, and practitioners looking to explore and implement AI solutions in healthcare.

RAAPID INC offers a neuro-symbolic AI-powered risk adjustment platform designed for health plans and providers. This platform delivers high accuracy (98%) and significant ROI (10:1) for HCC coding, ensuring audit-ready documentation. It provides solutions for retrospective, prospective, and RADV audit risk adjustment, linking every HCC to clinical proof for defensible coding. The AI reads, reasons, and defends every code, significantly reducing chart review times from months to days and cutting program costs by over 40%. RAAPID also offers AI as a Service (AIaaS) for seamless integration with existing systems and custom workflows, supporting an end-to-end value-based care journey.

Bambi is an AI-powered software solution specifically designed for Non-Emergency Medical Transportation (NEMT) businesses. It provides comprehensive tools for scheduling, routing, and dispatching, leveraging AI algorithms to optimize trip assignments and re-assignments for fleets. The platform aims to significantly increase daily operational efficiency, with claims of up to a 34% improvement. Key features include dynamic scheduling, real-time vehicle tracking, a dedicated NEMT Driver App for iOS and Android, and fleet management capabilities. Bambi also emphasizes personalized customer service, easy onboarding, and data-driven insights to enhance NEMT safety and operational gains. It integrates with major NEMT brokers and offers transparent, per-vehicle pricing.

The Artificial Intelligence in Medical Systems Society (AIMSS) is dedicated to advancing the responsible application of artificial intelligence within healthcare. AIMSS focuses on ensuring that AI technologies are developed and implemented ethically to improve patient care outcomes. The organization supports its mission through various initiatives, including conferences like AI x HEALTHCARE and UPPERBOUND, and educational programs such as their AI in Healthcare course. AIMSS aims to empower healthcare professionals and students with the knowledge and tools necessary to navigate the evolving landscape of AI in medical systems, fostering a community committed to responsible innovation.

InterLink AI, a company previously focused on data-driven pharmacy technology, has formally ceased its operations. The assets of the business have been acquired by Phoenix Pharmatech. Customers and interested parties are directed to Phoenix Pharmatech's website at phoenixpharmatech.com for any inquiries or to explore their offerings. The original InterLink AI aimed to provide solutions for pharmacies to enhance operational efficiency and prescription accuracy, with products designed for medication identification, dispensing, telepharmacy verification, and inventory management. The company's goal was to improve patient safety and overall pharmacy experiences through its AI-powered technologies.

Blank Bio is at the forefront of precision medicine, utilizing advanced RNA intelligence to transform drug development and clinical trials. The platform employs foundation models that integrate isoform, mutation, and expression signals from RNA, moving beyond traditional gene-level counts. This comprehensive approach allows for the identification of complex, multi-gene patterns that are often missed by conventional methods, leading to improved patient stratification, enhanced diagnostic accuracy, and more effective therapeutic design. Blank Bio's technology supports applications such as building multi-gene signatures for trial enrichment, refining disease classification, discovering new therapeutic targets, and optimizing RNA-based therapeutics. It also offers biosecurity monitoring through automated characterization of biological threats.

immunoMAPs is a premier computational platform designed to advance immunotherapy development through high-quality, end-to-end immunological data analysis. It assists small and medium enterprises (SMEs) in making data-driven decisions across the entire immunotherapies development life cycle. The platform utilizes advanced AI and machine learning models for immuno-informatics, enabling the identification of tumor antigens with immunopeptidomics, prediction of therapy responses to immune-checkpoint inhibitors, comprehensive TME analysis, and adverse event predictions. By integrating multi-omics datasets, immunoMAPs enhances the precision of peptide predictions and supports the design of novel immunotherapies, ultimately reducing risks in preclinical and clinical development.

Cydoc is an AI-powered scribe and triage assistant specifically developed for urgent care clinicians. This tool is designed to automate the time-consuming processes of history-taking and note writing, significantly reducing the administrative burden on healthcare professionals. By streamlining these tasks, Cydoc aims to save clinicians more than two hours per day, allowing them to focus more on patient care. The platform offers a free trial, enabling users to experience its benefits firsthand before committing. While specific features beyond automated history-taking and note writing are not detailed, the core value proposition revolves around efficiency and time-saving in a clinical setting.

Intradys is a medical software company dedicated to shaping the future of interventional neuroradiology. They develop a next-generation ecosystem for planning, guiding, and patient follow-up in this specialized medical field. Their technology integrates machine learning and mixed reality to empower interventional neuroradiologists, helping them deliver the best possible care to patients. Intradys also offers LUMYS, an immersive communication platform that leverages mixed reality. The company is based in Brest, France, and is actively seeking talented candidates in areas such as medical imaging, AI, 3D reconstruction, and data science.

immunitoAI is a TechBio company specializing in the development of AI-generated novel antibody therapeutics. Their platform focuses on 'Design over Discovery,' creating antibodies in silico without relying on biological sources, which aims to increase efficiency and expand the antibody space beyond natural repertoires. The company emphasizes 'Drug-First Antibodies,' embedding pre-defined drug properties at the inception of the design process to minimize the exploratory phase in drug developability. Utilizing a 'Structure-First AI Platform,' their neural networks are trained on shape complementarity for precise, target-specific design, optimizing affinity and specificity, and potentially opening possibilities for previously undruggable targets. immunitoAI's vision is to make antibody therapy the norm by unleashing the full potential of antibody-based biological drugs.

U-KAN is an official PyTorch implementation designed to serve as a robust backbone for medical image segmentation and generation. It leverages the innovative Kolmogorov-Anold Network (KAN) layers, integrating them into the established U-Net pipeline. This integration, termed U-KAN, aims to enhance accuracy and efficiency in medical imaging tasks. The tool has demonstrated superiority in rigorous medical image segmentation benchmarks, achieving higher accuracy with reduced computational cost. Furthermore, U-KAN explores its potential as an alternative U-Net noise predictor in diffusion models, showcasing its applicability in generating task-oriented model architectures. It is the first effort to incorporate KAN's advantages into the U-Net pipeline, offering a more accurate, efficient, and interpretable solution for vision tasks.

Monash DeepNeuron is a student team dedicated to the exploration and advancement of Artificial Intelligence (AI) and Optimised Computing (OC). Based at Monash University, the team focuses on empowering, engaging, and educating individuals in these fields. Through hands-on research projects, they equip students and researchers with essential skills and knowledge. The initiative fosters collaborative networks between students, academic staff, and industry partners to drive innovation and excellence. Monash DeepNeuron also emphasizes accessibility through community outreach events and educational initiatives, aiming to demystify AI and OC and promote understanding for broader participation in the digital revolution. Their diverse team includes members from various disciplines, working on projects across aerospace, science, medicine, gaming, and psychology.

Leap AI is a unique Venture Studio dedicated to launching disruptive startups that leverage generative AI within the healthcare sector. The company focuses on creating ethically-built technologies designed to revolutionize various aspects of healthcare, including clinical trials, patient care, and drug discovery. Their approach combines an interdisciplinary concept with proprietary technology platforms, deep domain expertise, and world-class know-how to efficiently operate within the constantly evolving healthcare ecosystem. Leap AI aims to generate and de-risk innovative ideas with high healthcare impact, value creation, and exit potential, prioritizing global healthcare outcomes and utilizing the latest technology. The studio model mitigates early risks and facilitates faster returns for investors by only launching startups with clear evidence of scalable profitability.

Finvi, formerly Ontariosystems.com, offers specialized AI-driven workflow platforms designed for revenue recovery in the Accounts Receivable Management (ARM) and Healthcare sectors. Their solutions, including Velosidy and Artiva HCx, leverage intelligent automation and AI-driven insights to streamline operations, improve agent efficiency, and accelerate financial outcomes. The platforms help organizations manage complex regulatory landscapes, reduce administrative workload, and minimize errors through features like automated workflows, AI-driven segmentation, and integrated payments. Finvi aims to transform how ARM and Healthcare organizations recover revenue, providing scalable and secure solutions that enhance productivity and compliance while delivering a better financial experience for customers and patients.

AI Medical Technology develops AI-powered diagnostic solutions for healthcare professionals. Their flagship product, Dermalyser, is a CE-marked app that provides AI-driven decision support for assessing suspected skin melanomas. By analyzing dermatoscopic images captured with a smartphone, Dermalyser offers immediate feedback with 96% accuracy (AUC), 95% sensitivity, and 85% specificity in melanoma detection. This tool is designed to optimize clinical workflow, reduce unnecessary referrals and procedures, and provide peace of mind for doctors. It is validated in prospective clinical studies and intended for licensed healthcare professionals like dermatologists and primary care physicians, acting as an assistant rather than a replacement for clinical judgment.

Compass Bioinformatics Inc. presents InheriNext, an AI-powered platform designed to streamline next-generation sequencing (NGS) analysis for inherited diseases. InheriNext features a cutting-edge variant ranking algorithm, intuitive design, and validated accuracy, empowering scientists and clinicians in hospitals and research laboratories. The platform supports data from most automated sequencing instruments, offering secure and optimized pipelines for complex variant calling from FASTQ or VCF formats. Users can identify and rank causative variants based on clinical phenotypes, in silico gene panels, or customized filters. InheriNext also provides custom report functionality for inherited diseases, including summaries and support for categorized variants. It automates routine tasks with accuracy and efficiency, ensuring consistency through baked-in ACMG guidelines and offering transparency by revealing all supporting evidence for its conclusions.

Reboot Rx is an independent nonprofit organization dedicated to advancing affordable cancer treatments by repurposing existing generic drugs. It leverages AI to aggregate and evaluate public clinical evidence, identifying generic medicines with strong data and potential impact in cancer care. The organization then supports additional research through partnerships and shares clear, synthesized findings with clinicians and health systems to inform decision-making in patient care. Reboot Rx focuses on areas where commercial incentives are lacking, providing unbiased information on treatments that can be added to standard care without manufacturing or profiting from drug sales.

Algocyte is an AI-powered solution developed by Oxford Immune Algorithmics for remote blood testing and personalized immune monitoring. It leverages Artificial General Intelligence (AGI) to learn from and monitor an individual's immune system, comparing it against health patterns and disease signatures to provide early detection of subtle blood changes. The system integrates subjective and objective data, including symptoms, lifestyle, and medical data from other portable, wearable devices, and EHR systems. This enables rapid intervention for chronic disease and remission monitoring, offering actionable insights across the patient care continuum. Algocyte aims to decentralize healthcare by providing a user-friendly, phone-controlled mobile health station capable of autonomous operation, delivering laboratory-level precision for self-testing at home.

Leal Health is a patient-first, AI-powered decision-making support platform dedicated to expediting access to advanced cancer treatment. It empowers patients to navigate their cancer journey by providing a personalized list of cutting-edge cancer treatments and clinical trials that match their exact diagnosis in minutes. The platform offers a free service with dedicated patient support from a team of PHDs, MDs, Nurses, and Social Workers. Leal Health prides itself on providing unbiased treatment options, ensuring that marketing spend does not influence recommendations. It has facilitated over 3,000,000 treatment matches and partners with leading advocacy organizations to democratize access to care.

Zencey is transforming healthcare in Africa by making it more equitable and accessible through a modern approach combining AI and Telemedicine. The platform offers comprehensive health plans for individuals, families, and small to midsize businesses, ensuring affordable access to medical consultations, pharmacies, hospitals, and diagnostic tests. Zencey's mobile app allows users to instantly connect with doctors, check symptoms, and receive personalized health solutions. For healthcare organizations, Zencey provides AI solutions like patient and doctor assistants, and patient health risk assessment APIs, enabling quick deployment and integration into existing digital health products. The service emphasizes timely care, security of medical information, and a seamless user experience.

Celeritas AI introduces Elsa, an AI teammate designed to enhance claims and order accuracy specifically for medical supplies and equipment companies. This platform aims to significantly improve claim processing time, reduce errors, and minimize the need for manual data entry. By integrating with existing order management software, Celeritas AI helps businesses increase revenue and decrease operational costs. The tool focuses on optimizing workflows and ensuring precision in critical business operations within the healthcare supply chain.

RadioView.AI transforms radiology workflows with its AI-powered software, offering automated reporting and accelerated imaging analysis. The platform features an AI-Viewer for unified multi-site access to DICOM images, AI-Chat for collaborative patient summary generation, and AI Measurements for automated segmentation and volumetric calculations. It streamlines report generation with RadReport, which creates structured, insightful reports in seconds, and RadEnhance, which provides smart suggestions to improve report completeness and billing accuracy. RadioView.AI integrates with existing PACS systems using DICOM, FHIR, and HL7 standards, and supports deployment across mobile, web, and desktop viewers, enhancing efficiency and reducing physician burnout.

CranioCatch is an AI-powered platform designed to revolutionize dental radiology by providing advanced diagnostic and analysis tools for dental professionals. It enhances the accuracy and efficiency of diagnosis and treatment planning through the use of sophisticated AI algorithms to evaluate various dental radiographs, including CBCT, panoramic, periapical, bitewing, and cephalometric images. The platform offers specialized modules for clinical practice, orthodontic analysis, educational purposes for dental students, and image labeling for AI model development. CranioCatch aims to streamline workflows, reduce diagnostic errors, and improve patient outcomes by automating radiological assessments and providing quick, reliable results.

Gosta Labs develops trustworthy AI systems specifically for healthcare professionals, aiming to advance patient care and medical practice. Their flagship product, Gosta Aide, acts as a personal AI assistant, automating note generation, structuring patient data, and supporting real-time decision-making across tens of thousands of clinical appointments. This leads to more accurate documentation, faster workflows, and higher-quality patient interactions. Gosta Labs also offers an API for leveraging their healthcare-specific models and partners with life sciences companies to integrate their AI into existing applications. Built in Europe on secure infrastructure, Gosta Labs emphasizes GDPR and EU AI Act compliance, ensuring safe and regulatory-compliant solutions.